HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 33.84m in AUM and 68 holdings. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.
What is the current price of Franklin Genomic Advancements ETF (HELX)?
The current price of Franklin Genomic Advancements ETF (HELX) is 41.58. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Franklin Genomic Advancements ETF?
The 52-week high of Franklin Genomic Advancements ETF is 46.22. Please refer to the page timestamp for the latest data.
What is the 52-week low of Franklin Genomic Advancements ETF?
The 52-week low of Franklin Genomic Advancements ETF is 31.24. Please refer to the page timestamp for the latest data.
What is the NAV of Franklin Genomic Advancements ETF?
The NAV of Franklin Genomic Advancements ETF is 42.97 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
Is Franklin Genomic Advancements ETF (HELX) a safe investment?
No investment is completely risk-free. The risk level of Franklin Genomic Advancements ETF (HELX) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.